https://www.selleckchem.com/products/etc-159.html
3 g/dl to 11.9 g/dl (p0.041); the hematocrit level decreased from 38.1% ± 4.8 to 36.9% ± 4.2 (p0.026); the median neutrophil count decreased from 4.57 K/uL to 3.85 K/uL (p0.001); the mean lymphocyte count increased from 1.22 ± 0.53 K/uL to 1.84 ± 1.19 K/uL (p0.00; and the mean platelet count increased from 244.1 ± 85.1 K/uL to 281.9 ± 103.3 K/uL (p0.005). We concluded that the pathological effect of treatment with favipiravir on the hematologic system was the suppression in the erythrocyte series, and there were no adverse effects in
Like
Comment
Share
